Yan Ling

1.8k total citations
87 papers, 1.3k citations indexed

About

Yan Ling is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Yan Ling has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Yan Ling's work include Lung Cancer Treatments and Mutations (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Yan Ling is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Yan Ling collaborates with scholars based in China, United States and Belgium. Yan Ling's co-authors include Xin Gao, David R. Clemmons, Qi Chen, Wei Wang, Fangjie Jiang, Pu Xia, Yan Yan, Xiaomu Li, Laura A. Maile and Tianyu Zhai and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Ling

85 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ling China 21 518 328 250 200 200 87 1.3k
Dongxing Zhu United Kingdom 22 676 1.3× 262 0.8× 147 0.6× 144 0.7× 219 1.1× 42 1.7k
Meiping Guan China 25 751 1.4× 348 1.1× 352 1.4× 266 1.3× 189 0.9× 56 1.6k
Zongji Zheng China 25 781 1.5× 209 0.6× 414 1.7× 189 0.9× 235 1.2× 42 1.5k
Ming‐Jiang Xu China 22 626 1.2× 128 0.4× 194 0.8× 230 1.1× 250 1.3× 37 1.7k
Sushma Kaul United States 19 647 1.2× 143 0.4× 232 0.9× 216 1.1× 184 0.9× 32 1.4k
Shufang Wu China 27 744 1.4× 233 0.7× 243 1.0× 178 0.9× 208 1.0× 66 1.8k
Christos Adamopoulos Greece 28 887 1.7× 179 0.5× 227 0.9× 112 0.6× 167 0.8× 57 2.0k
Aleksandra Stanković Serbia 18 367 0.7× 155 0.5× 235 0.9× 88 0.4× 108 0.5× 125 1.1k
Jingang Zheng China 20 413 0.8× 177 0.5× 210 0.8× 288 1.4× 151 0.8× 94 1.5k
Giulia Cantini Italy 23 540 1.0× 449 1.4× 311 1.2× 528 2.6× 171 0.9× 61 1.6k

Countries citing papers authored by Yan Ling

Since Specialization
Citations

This map shows the geographic impact of Yan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ling more than expected).

Fields of papers citing papers by Yan Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ling. The network helps show where Yan Ling may publish in the future.

Co-authorship network of co-authors of Yan Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ling. A scholar is included among the top collaborators of Yan Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ling. Yan Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Yan, Xiaojuan Song, Zhang Lin, et al.. (2025). Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1H-indole-3-yl)-5H-pyrrolo[2,3-b]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance. Journal of Medicinal Chemistry. 68(18). 19415–19437. 1 indexed citations
2.
Qin, Bao‐Dong, Xiao‐Dong Jiao, Zhan Wang, et al.. (2023). Pan‐cancer efficacy and safety of anlotinib plus PD ‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial. International Journal of Cancer. 153(4). 815–825. 9 indexed citations
3.
4.
5.
He, Xi, Xiao‐Dong Jiao, Ke Liu, et al.. (2021). Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report. JCO Precision Oncology. 5(5). 771–778. 10 indexed citations
6.
7.
Ling, Yan, Yiming Xu, Li G, et al.. (2019). Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Jiang, Lirong, Yan Ling, Zhong‐Ming Qian, et al.. (2017). Nifedipine Increases Iron Content in WKPT-0293 Cl.2 Cells via Up-Regulating Iron Influx Proteins. Frontiers in Pharmacology. 8. 60–60. 2 indexed citations
9.
Jiang, Jingjing, Lin Zhao, Lin Liu, et al.. (2017). Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease. Scientific Reports. 7(1). 14212–14212. 22 indexed citations
10.
11.
12.
Peng, Cheng, Yan Ling, Xiaochun Ma, et al.. (2016). Safety Outcomes of NOTES Cholecystectomy Versus Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 26(5). 347–353. 30 indexed citations
13.
Ling, Yan, et al.. (2016). Application of SonoVue combined with three-dimensional color power angiography in the diagnosis and prognosis evaluation of intrauterine adhesion. European Journal of Obstetrics & Gynecology and Reproductive Biology. 198. 68–72. 6 indexed citations
14.
15.
Ling, Yan, Xiaomu Li, & Xin Gao. (2013). Cross-sectional association of serum C-reactive protein and uric acid with albuminuria in Chinese type 2 diabetic patients. Chinese Medical Journal. 126(21). 4023–4029. 6 indexed citations
16.
Zhang, Ying-xiu, et al.. (2013). Association between body mass index, skinfold thickness and blood pressure in 12-year-old children. European Journal of Pediatrics. 172(9). 1167–1171. 5 indexed citations
17.
Kellis, M, Yan Ling, Daru Lu, et al.. (2013). Common Polymorphism rs11191548 Near the CYP17A1 Gene Is Associated With Hypertension and Systolic Blood Pressure in the Han Chinese Population. American Journal of Hypertension. 26(4). 465–472. 16 indexed citations
18.
19.
Ling, Yan, Xiaomu Li, Qian Gu, et al.. (2011). A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovascular Diabetology. 10(1). 27–27. 25 indexed citations
20.
Lieskovská, Jaroslava, et al.. (2006). The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 281(35). 25041–25053. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongxing Zhu Breakdown of academic impact, for papers by Meiping Guan Breakdown of academic impact, for papers by Zongji Zheng Breakdown of academic impact, for papers by Ming‐Jiang Xu Breakdown of academic impact, for papers by Sushma Kaul Breakdown of academic impact, for papers by Shufang Wu Breakdown of academic impact, for papers by Christos Adamopoulos Breakdown of academic impact, for papers by Aleksandra Stanković Breakdown of academic impact, for papers by Jingang Zheng Breakdown of academic impact, for papers by Giulia Cantini
Rankless by CCL
2026